EMEA-002293-PIP01-17

Key facts

Active substance
Calcium, N,N'-1,2-ethanediylbis[N-[[3-(hydroxy-2-methyl-5-[(phosphonooxy)methyl]-4-pyridinyl]methyl]glycine] manganese complexes
Therapeutic area
Oncology
Decision number
P/0115/2018
PIP number
EMEA-002293-PIP01-17
Pharmaceutical form(s)
Solution for infusion
Condition(s) / indication(s)
Prevention of oxaliplatin induced peripheral neuropathy
Route(s) of administration
Intravenous use
Contact for public enquiries
PledPharma AB
Tel.: +46 708368702
E-mail: malin.nittve@pledpharma.se
Decision type
W: decision granting a waiver in all age groups for all conditions/indications

Decision

How useful was this page?

Add your rating